Chemomab Therapeutics Ltd ADR (NASDAQ:CMMB)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - CMMB

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - CMMB

  • Market Cap$181.870m
  • SymbolNASDAQ:CMMB
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS16385C1045

Company Profile

Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet need. The company's lead candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.

Latest CMMB news

Currently there for this company. Visit our news hub for other news .